The Original Investigation titled “Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke: The ATAMIS Randomized Clinical Trial,”1 published on March 11, 2024, was corrected to fix the 95% CI for the overall risk difference reported in Figure 3 from −3.6% to 0.2% to is −3.6% to −0.2%. This article was corrected online.
Reference
- 1.Chen HS, Cui Y, Wang X-H, et al. ; ATAMIS Investigators . Clopidogrel plus aspirin vs aspirin alone in patients with acute mild to moderate stroke: the ATAMIS randomized clinical trial. JAMA Neurol. Published online March 11, 2024. doi: 10.1001/jamaneurol.2024.0146 [DOI] [PMC free article] [PubMed] [Google Scholar]